Literature DB >> 2418115

Higher frequency of Leishmania major-specific L3T4+ T cells in susceptible BALB/c as compared with resistant CBA mice.

G Milon, R G Titus, J C Cerottini, G Marchal, J A Louis.   

Abstract

In previous studies, we reported that a) the adoptive transfer of parasite-specific L3T4+ T cells enhanced rather than inhibited the development of lesions induced by Leishmania major in normal BALB/c mice, and b) the depletion in vivo of L3T4+ T cells by administration of anti-L3T4 monoclonal antibody reversed the susceptibility of BALB/c mice to L. major. To further assess the role of specific L3T4+ T cells in the development of lesions induced by L. major in BALB/c mice, the frequency of parasite-specific T cells capable of mediating specific delayed-type hypersensitivity (DTH) reactivity was determined, by limiting dilution analysis, in the lymph nodes draining the lesions of susceptible (BALB/c) and resistant (CBA) mice. The numbers of L. major-specific DTH-mediating T cells was found to be substantially increased in the lymph nodes of infected BALB/c mice as compared with CBA mice. Moreover in CBA mice, analysis of the cell surface phenotype of the L. major-specific DTH-mediating T cells showed that these cells were equally represented in the L3T4+, Lyt-2-, and L3T4- Lyt-2+ subsets, whereas the majority of these cells in BALB/c mice expressed the L3T4+ Lyt-2- surface phenotype.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2418115

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Systemic cytokine response in humans with chiclero's ulcers.

Authors:  C M Lezama-Davila; A P Isaac-Marquez
Journal:  Parasitol Res       Date:  2006-04-22       Impact factor: 2.289

Review 2.  Cutaneous leishmaniasis: a model for analysis of the immunoregulation by accessory cells.

Authors:  H Moll; U Ritter; S Flohé; K Erb; C Bauer; C Blank
Journal:  Med Microbiol Immunol       Date:  1996-02       Impact factor: 3.402

3.  Effect of CD4 monoclonal antibody in vivo on lesion development, delayed-type hypersensitivity and interleukin 3 production in experimental murine cutaneous leishmaniasis.

Authors:  F Y Liew; S Millott; R Lelchuk; S Cobbold; H Waldmann
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

4.  The cellular immune response to a purified antigen from Leishmania mexicana subsp. amazonensis enhances the size of the leishmanial lesion on susceptible mice.

Authors:  M M Rodrigues; L Mendonça-Previato; R Charlab; M A Barcinski
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

5.  Expansion of gamma interferon-producing CD8+ T cells following secondary infection of mice immune to Leishmania major.

Authors:  I Müller; P Kropf; J A Louis; G Milon
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

6.  T lymphocytes mediate protection against Yersinia enterocolitica in mice: characterization of murine T-cell clones specific for Y. enterocolitica.

Authors:  I B Autenrieth; A Tingle; A Reske-Kunz; J Heesemann
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

7.  Gamma interferon response in secondary Leishmania major infection: role of CD8+ T cells.

Authors:  I Müller; P Kropf; R J Etges; J A Louis
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

Review 8.  Immunobiology of experimental leishmaniasis.

Authors:  I Müller; U Fruth; J A Louis
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

9.  Kinetics of cell-mediated immunity developing during the course of Leishmania major infection in 'healer' and 'non-healer' mice: progressive impairment of response to and generation of interleukin-2.

Authors:  W Solbach; M Lohoff; H Streck; P Rohwer; M Röllinghoff
Journal:  Immunology       Date:  1987-11       Impact factor: 7.397

10.  Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum.

Authors:  E Pinelli; R Killick-Kendrick; J Wagenaar; W Bernadina; G del Real; J Ruitenberg
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.